These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Course of disease and treatment policy in suspected low-grade glioma].
    Author: Sizoo EM, Reijneveld JC, Lagerwaard FJ, Buter J, Taphoorn MJ, Hamer PC.
    Journal: Ned Tijdschr Geneeskd; 2010; 154():A1367. PubMed ID: 20170560.
    Abstract:
    Watchful waiting has long been justified in the Netherlands for patients in whom a low-grade glioma is suspected. According to recent advances in knowledge it is clear that the course of a suspected low-grade glioma cannot be reliably determined by clinical characteristics, imaging or biopsy. Early resection of the tumour provides a histological diagnosis, the possibility of removing a source of epilepsy and postponement of tumour growth and progression. Alleviation of symptoms, sustained quality of life and cognition are at least as important an aim of treatment as survival and postponement of tumour progression. In our opinion, early resection should be strongly considered in every patient with a suspected low-grade glioma. However, radiotherapy or chemotherapy should only be considered early in the presence of unfavourable prognostic factors or persistent epilepsy. Each patient in whom a low-grade glioma is suspected should receive specific treatment advice from a neuro-oncological team.
    [Abstract] [Full Text] [Related] [New Search]